| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $77.4M | -37.8% |
| Cost of Revenue | $59.9M | -33.8% |
| Gross Profit | $17.5M | -48.4% |
| R&D Expense | $1.9M | +8.9% |
| SG&A Expense | $19.5M | +66.8% |
| Operating Income | -$16.0M | -290.5% |
| Pre-tax Income | -$16.4M | -298.3% |
| Income Tax | $18.0M | +732.7% |
| Net Income | -$34.3M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $16.0M | +10.5% |
| Accounts Receivable | $13.7M | +15.4% |
| Inventory | $18.2M | -8.2% |
| Current Assets | $50.4M | -1.7% |
| Total Assets | $71.6M | -17.6% |
| Current Liabilities | $24.5M | +33.1% |
| Long-term Debt | $10.0M | — |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | -1927.4% |
| Capital Expenditures | $586K | +13.1% |
| Investing Cash Flow | -$6.2M | -26.0% |
| Financing Cash Flow | $10.0M | +9526.9% |
| Free Cash Flow | -$2.9M | -355.9% |
| -663.8% |
| EPS (Basic) | -$1.08 | -640.0% |
| EPS (Diluted) | -$1.08 | -668.4% |
| Total Liabilities |
| $38.3M |
| +76.5% |
| Stockholders' Equity | $33.2M | -48.9% |